News | January 10, 2024
Hikal invests Rs. 500 crore into fine chemicals plant at Panoli
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of US $5 million in the US
The National Sickle Cell Anaemia Elimination Mission was launched on 1st July 2023 at Shahdol, Madhya Pradesh
The company received gross proceeds of approximately US$1.7 million and net proceeds,
The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year
AMI to become part of Enpro’s Sealing Technologies Segment
According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.
The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year
Subscribe To Our Newsletter & Stay Updated
